Cargando…
Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax
BACKGROUND: Secondary spontaneous pneumothorax (SSP) in interstitial lung disease (ILD) may influence prognosis of any ILD, and SSP onset predicts poor outcome in idiopathic pulmonary fibrosis (IPF). Recently, progressive fibrosing ILD (PF-ILD) has rapidly acquired importance. OBJECTIVE: We hypothes...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787380/ https://www.ncbi.nlm.nih.gov/pubmed/35115749 http://dx.doi.org/10.36141/svdld.v38i4.11465 |
_version_ | 1784639351305535488 |
---|---|
author | Yamakawa, Hideaki Tsukahara, Yuta Sato, Shintaro Ohta, Hiroki Kida, Gen Nakamura, Tomohiko Nishizawa, Tomotaka Kawabe, Rie Oba, Tomohiro Akasaka, Keiichi Amano, Masako Kuwano, Kazuyoshi Sasaki, Hiroki Takemura, Tamiko Matsushima, Hidekazu |
author_facet | Yamakawa, Hideaki Tsukahara, Yuta Sato, Shintaro Ohta, Hiroki Kida, Gen Nakamura, Tomohiko Nishizawa, Tomotaka Kawabe, Rie Oba, Tomohiro Akasaka, Keiichi Amano, Masako Kuwano, Kazuyoshi Sasaki, Hiroki Takemura, Tamiko Matsushima, Hidekazu |
author_sort | Yamakawa, Hideaki |
collection | PubMed |
description | BACKGROUND: Secondary spontaneous pneumothorax (SSP) in interstitial lung disease (ILD) may influence prognosis of any ILD, and SSP onset predicts poor outcome in idiopathic pulmonary fibrosis (IPF). Recently, progressive fibrosing ILD (PF-ILD) has rapidly acquired importance. OBJECTIVE: We hypothesized that PF-ILD would strongly influence the prognosis of patients with any ILD complicated with SSP. METHODS: We retrospectively surveyed and collected data from patients hospitalized for SSP from January 2016 to June 2020. PF-ILD was defined as the following occurring within 24 months before SSP develops: relative decline in %forced vital capacity (FVC) ≥10% or two of the following: relative decline in %FVC between 5% and 10%, worsening respiratory symptoms, or increased extent of fibrosis on high-resolution computed tomography. RESULTS: We analyzed 32 patients hospitalized for SSP in ILD. This study comprised 18 patients with PF-ILD and 14 patients with non-PF-ILD. PF-ILD patients had lower body mass index (BMI) and %FVC. No significant differences in survival regarding follow-up period from the time of ILD diagnosis and hospitalization for SSP were observed between the PF-ILD and non-PF-ILD patients. Older age and lower BMI were significant predictors of mortality by multivariate Cox regression analysis. ROC analysis showed BMI ≤17.8 kg/m(2) to reliably predict poor prognosis. CONCLUSIONS: Regardless of whether patients have PF-ILD, older age and lower BMI in patients with ILD places them at higher risk of developing SSP, and prognosis is poor if SSP develops. Therefore, clinical management of physique is important to improve the prognosis of ILD patients. |
format | Online Article Text |
id | pubmed-8787380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Mattioli 1885 |
record_format | MEDLINE/PubMed |
spelling | pubmed-87873802022-02-02 Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax Yamakawa, Hideaki Tsukahara, Yuta Sato, Shintaro Ohta, Hiroki Kida, Gen Nakamura, Tomohiko Nishizawa, Tomotaka Kawabe, Rie Oba, Tomohiro Akasaka, Keiichi Amano, Masako Kuwano, Kazuyoshi Sasaki, Hiroki Takemura, Tamiko Matsushima, Hidekazu Sarcoidosis Vasc Diffuse Lung Dis Original Article: Clinical Research BACKGROUND: Secondary spontaneous pneumothorax (SSP) in interstitial lung disease (ILD) may influence prognosis of any ILD, and SSP onset predicts poor outcome in idiopathic pulmonary fibrosis (IPF). Recently, progressive fibrosing ILD (PF-ILD) has rapidly acquired importance. OBJECTIVE: We hypothesized that PF-ILD would strongly influence the prognosis of patients with any ILD complicated with SSP. METHODS: We retrospectively surveyed and collected data from patients hospitalized for SSP from January 2016 to June 2020. PF-ILD was defined as the following occurring within 24 months before SSP develops: relative decline in %forced vital capacity (FVC) ≥10% or two of the following: relative decline in %FVC between 5% and 10%, worsening respiratory symptoms, or increased extent of fibrosis on high-resolution computed tomography. RESULTS: We analyzed 32 patients hospitalized for SSP in ILD. This study comprised 18 patients with PF-ILD and 14 patients with non-PF-ILD. PF-ILD patients had lower body mass index (BMI) and %FVC. No significant differences in survival regarding follow-up period from the time of ILD diagnosis and hospitalization for SSP were observed between the PF-ILD and non-PF-ILD patients. Older age and lower BMI were significant predictors of mortality by multivariate Cox regression analysis. ROC analysis showed BMI ≤17.8 kg/m(2) to reliably predict poor prognosis. CONCLUSIONS: Regardless of whether patients have PF-ILD, older age and lower BMI in patients with ILD places them at higher risk of developing SSP, and prognosis is poor if SSP develops. Therefore, clinical management of physique is important to improve the prognosis of ILD patients. Mattioli 1885 2021 2021-12-31 /pmc/articles/PMC8787380/ /pubmed/35115749 http://dx.doi.org/10.36141/svdld.v38i4.11465 Text en Copyright: © 2021 SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License |
spellingShingle | Original Article: Clinical Research Yamakawa, Hideaki Tsukahara, Yuta Sato, Shintaro Ohta, Hiroki Kida, Gen Nakamura, Tomohiko Nishizawa, Tomotaka Kawabe, Rie Oba, Tomohiro Akasaka, Keiichi Amano, Masako Kuwano, Kazuyoshi Sasaki, Hiroki Takemura, Tamiko Matsushima, Hidekazu Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax |
title | Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax |
title_full | Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax |
title_fullStr | Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax |
title_full_unstemmed | Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax |
title_short | Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax |
title_sort | impact of progressive fibrosing interstitial lung disease (ild) in ild patients complicated with secondary spontaneous pneumothorax |
topic | Original Article: Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787380/ https://www.ncbi.nlm.nih.gov/pubmed/35115749 http://dx.doi.org/10.36141/svdld.v38i4.11465 |
work_keys_str_mv | AT yamakawahideaki impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax AT tsukaharayuta impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax AT satoshintaro impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax AT ohtahiroki impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax AT kidagen impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax AT nakamuratomohiko impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax AT nishizawatomotaka impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax AT kawaberie impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax AT obatomohiro impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax AT akasakakeiichi impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax AT amanomasako impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax AT kuwanokazuyoshi impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax AT sasakihiroki impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax AT takemuratamiko impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax AT matsushimahidekazu impactofprogressivefibrosinginterstitiallungdiseaseildinildpatientscomplicatedwithsecondaryspontaneouspneumothorax |